跳至主要内容
临床试验/CTRI/2025/10/096684
CTRI/2025/10/096684招募中Unknown

Arthroscopy Implants for Knee:A Prospective, Observational, Multi-centre, Single-arm, Open-label, Post-market Clinical Followup Study to Evaluate Safety and Performance of the Arthroscopy Implants for Knee in a RealWorld Setting.

Meril Life Sciences Pvt Ltd4 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2025年11月29日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
107
试验地点
4
主要终点
1.Implant failure rate

研究概览

简要总结

Study Name: A Prospective, Observational, Multi-centre, Single-arm, Openlabel, Post-market Clinical Follow-up Study to Evaluate Safety and Performance of the Arthroscopy Implants for Knee in a RealWorld Setting.

Short Title: Arthroscopy Implants for Knee

Objective: The study aims to evaluate the safety and performance of arthroscopy implants in participants undergoing knee surgeries.

Study Design: A Prospective, Observational, Multi-centre, Single-arm, Openlabel, Post-market Clinical Follow-up Study.

Rationale of the Study Arthroscopy implants have become essential tools in minimally invasive orthopedic procedures, particularly for treating conditions in the shoulder, elbow, and hand/wrist joints. These procedures allow for targeted interventions, offering participants faster recovery times, less post- operative pain, and improved mobility compared to traditional open surgeries. However, there remains a need to comprehensively assess the safety and performance of these implants in real- world settings, where participant populations may vary significantly from clinical trials. This study is designed to evaluate the safety and performance of arthroscopy implants in Participants undergoing knee surgeries

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Arthroscopy Knee System implants are intended to be used in both men and non-pregnant women of age 18 years or above.
  • The Participants who are eligible for the arthroscopy system which is used in the surgical procedures related to knee ligament fracture fixation are included in the study.
  • The Participants who require connective tissue tendon repairs for the knees.
  • Participants who require the attachment of soft tissue grafts or bone-tendon grafts to the tibia and/or femur during cruciate ligament reconstruction surgeries and fixation of soft tissue.
  • The patient is willing and able to comply with postoperative scheduled clinical evaluations.

排除标准

  • 1.Systemic or acute or chronic infection at the surgical site.
  • Known allergy or sensitivity to product materials.
  • Any medical or surgical condition that would preclude the potential benefit of the operation.
  • Fever or leukocytosis.
  • Long-term infection, pregnancy and nursing, radiation bone therapy, cardiovascular diseases, metabolic bone disease, renal diseases, and pediatric Participants should not be included in the study.
  • Participants within whom cooperation or mental competence is lacking, thereby reducing Participants compliance.
  • The Participants, being considered for treatment by a doctor, would not comply with the follow-up schedule.
  • Participants who is unwilling or unsuitable for postoperative instructions.
  • The Participants who is unwilling or unable to sign the Informed Consent Document will be excluded from the study.

结局指标

主要结局

1.Implant failure rate

时间窗: 1.Time Frame: Intra-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years | 2.Time Frame: 3 weeks, 3 months, 6 months, 1 year, 2 years | 3.Time Frame: Pre-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years

2.Reoperation rate

时间窗: 1.Time Frame: Intra-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years | 2.Time Frame: 3 weeks, 3 months, 6 months, 1 year, 2 years | 3.Time Frame: Pre-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years

3.Physical Function

时间窗: 1.Time Frame: Intra-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years | 2.Time Frame: 3 weeks, 3 months, 6 months, 1 year, 2 years | 3.Time Frame: Pre-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years

次要结局

  • 1.Implant failure rate(2.Reoperation rate)

研究者

发起方
Meril Life Sciences Pvt Ltd
申办方类型
Other [Medical Device Company ]
责任方
Principal Investigator
主要研究者

Dr Kirankumar Shetty

Meril Life Sciences Pvt. Ltd

研究点 (4)

Loading locations...

相似试验